Cytokinetics And Royalty Pharma Announce Funding Agreements Totaling Up To $450 Million
Round Type
Funding Round
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Cytokinetics, Incorporated (Nasdaq: CYTK) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Cytokinetics has secured long-term capital from Royalty Pharma to support the potential commercialization of omecamtiv mecarbil and the further development of aficamten. In addition, Cytokinetics sold to Royalty Pharma royalties on future worldwide sales of aficamten.
Quick answer
Cytokinetics raised an undisclosed amount in a Funding Round round, dated January 7, 2022. Cytokinetics is based in South San Francisco, California, United States.
- How much did Cytokinetics raise?
- Cytokinetics raised an undisclosed amount in a Funding Round round on January 7, 2022.
- What does Cytokinetics do?
- Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating..
- Where is Cytokinetics based and how big is it?
- Cytokinetics is based in South San Francisco, California, United States. Fundz records about 694 employees.
- Who are the decision-makers at Cytokinetics?
- Fundz holds 1 contact at Cytokinetics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cytokinetics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
- Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
- Centaurus Therapeutics raised $31M (Series A) on February 16, 2022.
- Arsenal Biosciences raised $221M on February 10, 2022.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
Who to call at Cytokinetics, and when
A new round usually means Cytokinetics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cytokinetics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cytokinetics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cytokinetics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cytokinetics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cytokinetics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.